Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease
- PMID: 2361014
- DOI: 10.1016/0896-6273(90)90144-5
Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease
Abstract
To test the hypothesis that cortical neurons undergo massive sprouting in Alzheimer's disease brain, we investigated whether neurofibrillary tangles contain fetal antigens. Two monoclonal antibodies to tangles specifically labeled an approximately 300 kd protein in the neonatal brain homogenate, which was subsequently identified as MAP5 (MAP1B). Conversely, two monoclonal antibodies to MAP5 were found to stain tangles. All four reacted with only a phosphorylated species of MAP5. By careful immunochemical analysis, at least three independent phosphorylated epitopes that should have distinct conformations were shown to be shared by tangles and MAP5. However, several monoclonal antibodies to nonphosphorylated MAP5 did not stain tangles. From these observations, we conclude that fragments of phosphorylated MAP5 are bound to tangles. Since MAP5, in particular, a phosphorylated species, is known to be involved in neurite outgrowth, this result supports the sprouting hypothesis.
Similar articles
-
Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.Acta Neuropathol. 1991;81(6):626-31. doi: 10.1007/BF00296372. Acta Neuropathol. 1991. PMID: 1909079
-
Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.J Neurochem. 1996 Dec;67(6):2405-16. doi: 10.1046/j.1471-4159.1996.67062405.x. J Neurochem. 1996. PMID: 8931473
-
Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.Proc Natl Acad Sci U S A. 1987 May;84(10):3415-9. doi: 10.1073/pnas.84.10.3415. Proc Natl Acad Sci U S A. 1987. PMID: 3106969 Free PMC article.
-
Neurofibrillary tangles and the neuronal cytoskeleton.J Neural Transm Suppl. 1987;24:191-6. J Neural Transm Suppl. 1987. PMID: 3119774 Review.
-
Pathologic changes in olfactory neurons in Alzheimer's disease.Ann N Y Acad Sci. 1991;640:1-7. doi: 10.1111/j.1749-6632.1991.tb00182.x. Ann N Y Acad Sci. 1991. PMID: 1776726 Review.
Cited by
-
Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels.Commun Biol. 2022 Apr 8;5(1):336. doi: 10.1038/s42003-022-03287-y. Commun Biol. 2022. PMID: 35396452 Free PMC article.
-
Tau Protein Interaction Partners and Their Roles in Alzheimer's Disease and Other Tauopathies.Int J Mol Sci. 2021 Aug 26;22(17):9207. doi: 10.3390/ijms22179207. Int J Mol Sci. 2021. PMID: 34502116 Free PMC article. Review.
-
Neurodegenerative disease biomarkers Aβ1-40, Aβ1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy.Brain Behav. 2018 Jan 13;8(2):e00903. doi: 10.1002/brb3.903. eCollection 2018 Feb. Brain Behav. 2018. PMID: 29484263 Free PMC article.
-
Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.J Neurosci. 2014 May 21;34(21):7124-36. doi: 10.1523/JNEUROSCI.3439-13.2014. J Neurosci. 2014. PMID: 24849348 Free PMC article.
-
Cellular and molecular characterization of multipolar Map5-expressing cells: a subset of newly generated, stage-specific parenchymal cells in the mammalian central nervous system.PLoS One. 2013 May 7;8(5):e63258. doi: 10.1371/journal.pone.0063258. Print 2013. PLoS One. 2013. PMID: 23667595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
